Citizens JMP Slashes PT on OrthoPediatrics (KIDS) to $35 From $50, Keeps an Outperform Rating

OrthoPediatrics Corp. (NASDAQ:KIDS) is one of the best medical device stocks to buy according to analystsOn August 8, Citizens JMP analyst David Turkaly lowered the firm’s price target on OrthoPediatrics Corp. (NASDAQ:KIDS) to $35 from $50 while keeping an Outperform rating on the shares.

A cutting edge medical device in a sterile surgical setting, being operated by a skilled surgeon.

The analyst told investors in a research note that OrthoPediatrics Corp. (NASDAQ:KIDS) reported a quarterly record on its top line.

He added that while adjusted EBITDA and revenues were shy of consensus, OrthoPediatrics Corp. (NASDAQ:KIDS) is continually taking share in all its key market segments.

Management also reiterated the full-year guidance, leading the analyst to believe that the company’s fundamentals remain solid.

OrthoPediatrics Corp. (NASDAQ:KIDS) is an orthopedic company that designs, develops, and markets anatomically appropriate implants and devices for children with orthopedic conditions. The company’s offerings include products related to sports medicine, trauma, deformity, scoliosis, and other procedures.

While we acknowledge the potential of KIDS to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KIDS and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.